Beadták az első embernek az oltást, ami visszafordítja az öregedést

A US-based company, Life Bioscience, is developing a gene therapy aimed at reversing the aging process in the eyes of glaucoma patients. The treatment seeks to rejuvenate ocular tissues, potentially restoring vision for those affected by the condition. This innovative approach targets the cellular mechanisms of aging within the eye. Early trials are focused on demonstrating the therapy's efficacy and safety in a human subject.

This development could offer a groundbreaking new treatment for glaucoma and potentially other age-related eye conditions, representing a significant advancement in regenerative medicine.